文献速递糖尿病

2型糖尿病患者坐骨神经结构完整性下降与不同周围感觉表型相关

A diminished sciatic nerve structural integrity is associated with distinct peripheral sensory phenotypes in individuals with type 2 diabetes.
PubMed 文献 · Diabetologia · 2023-11-29

该横断面研究纳入76例2型糖尿病患者,基于定量感觉测试分为健康感觉型(HSP)、热痛觉过敏(TH)、机械痛觉过敏(MH)和感觉丧失(SL)四种表型,并采用高分辨率磁共振神经成像测定右侧坐骨神经远端部分各向异性(FA)和横截面积(CSA)。结果显示FA从HSP至SL逐渐降低(p=0.005),CSA逐渐增大(p=0.011);MH和SL与较低的FA及较大的CSA独立相关。结论认为最严重感觉表型(MH和SL)存在坐骨神经结构完整性下降,可能代表进展性轴索丢失。

要点

  • 2型糖尿病患者坐骨神经FA从HSP至SL逐渐降低(HSP 0.444 vs SL 0.382,p=0.005)。
  • 坐骨神经CSA从HSP至SL逐渐增大(HSP 21.7 vs SL 25.8 mm²,p=0.011)。
  • MH和SL表型与较低FA及较大CSA独立相关,TH表型未见此结构改变。

核心结论

  • DSPN最严重感觉表型(MH和SL)表现为坐骨神经结构完整性下降(FA较低)及CSA增大,可能代表进展性轴索丢失,而TH患者未检测到此种改变。
  • 2型糖尿病患者在病程中可能经历从健康到TH、MH、最终SL的预设神经纤维损伤级联,近端神经结构改变似乎先于周围神经感觉丧失,并提示预防终末期DSPN的潜在靶点。

研究设计与样本

  • 横断面研究,纳入76例2型糖尿病患者,进行右足定量感觉测试(QST)及右坐骨神经远端高分辨率磁共振神经成像(含弥散张量成像),测定FA和CSA。
  • 通过基于QST的标准分类算法将参与者分为四种感觉表型:健康感觉型(HSP)、热痛觉过敏(TH)、机械痛觉过敏(MH)和感觉丧失(SL)。
  • 试验注册号:ClinicalTrials.gov NCT03022721。

主要发现

  • 客观神经功能缺损从HSP、TH、MH至SL组逐渐加重,MH高于HSP,SL高于HSP和TH。
  • HSP、TH、MH和SL组人数分别为16、24、17和19例。
  • 坐骨神经FA从HSP至SL逐渐降低:HSP 0.444、TH 0.437、MH 0.395、SL 0.382(p=0.005)。
  • 坐骨神经CSA从HSP至SL逐渐增大:HSP 21.7、TH 21.5、MH 25.9、SL 25.8 mm²(p=0.011)。
  • 多变量回归分析中,MH与较低FA相关(非标准化回归系数B=-0.048,95%CI -0.091至-0.006,p=0.027)及较大CSA相关(β=4.3,95%CI 0.5至8.0,p=0.028);SL与较低FA相关(B=-0.062,95%CI -0.103至-0.020,p=0.004)及较大CSA相关(B=4.0,95%CI 0.4至7.7,p=0.032)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Quantitative sensory testing (QST) allows the identification of individuals with rapid progression of diabetic sensorimotor polyneuropathy (DSPN) based on certain sensory phenotypes. Hence, the aim of this study was to investigate the relationship of these phenotypes with the structural integrity of the sciatic nerve among individuals with type 2 diabetes. METHODS: Seventy-six individuals with type 2 diabetes took part in this cross-sectional study and underwent QST of the right foot and high-resolution magnetic resonance neurography including diffusion tensor imaging of the right distal sciatic nerve to determine the sciatic nerve fractional anisotropy (FA) and cross-sectional area (CSA), both of which serve as markers of structural integrity of peripheral nerves. Participants were then assigned to four sensory phenotypes (participants with type 2 diabetes and healthy sensory profile [HSP], thermal hyperalgesia [TH], mechanical hyperalgesia [MH], sensory loss [SL]) by a standardised sorting algorithm based on QST. RESULTS: Objective neurological deficits showed a gradual increase across HSP, TH, MH and SL groups, being higher in MH compared with HSP and in SL compared with HSP and TH. The number of participants categorised as HSP, TH, MH and SL was 16, 24, 17 and 19, respectively. There was a gradual decrease of the sciatic nerve's FA (HSP 0.444, TH 0.437, MH 0.395, SL 0.382; p=0.005) and increase of CSA (HSP 21.7, TH 21.5, MH 25.9, SL 25.8 mm2; p=0.011) across the four phenotypes. Further, MH and SL were associated with a lower sciatic FA (MH unstandardised regression coefficient [B]=-0.048 [95% CI -0.091, -0.006], p=0.027; SL B=-0.062 [95% CI -0.103, -0.020], p=0.004) and CSA (MH β=4.3 [95% CI 0.5, 8.0], p=0.028; SL B=4.0 [95% CI 0.4, 7.7], p=0.032) in a multivariable regression analysis. The sciatic FA correlated negatively with the sciatic CSA (r=-0.35, p=0.002) and markers of microvascular damage (high-sensitivity troponin T, urine albumin/creatinine ratio). CONCLUSIONS/INTERPRETATION: The most severe sensory phenotypes of DSPN (MH and SL) showed diminishing sciatic nerve structural integrity indexed by lower FA, likely representing progressive axonal loss, as well as increasing CSA of the sciatic nerve, which cannot be detected in individuals with TH. Individuals with type 2 diabetes may experience a predefined cascade of nerve fibre damage in the course of the disease, from healthy to TH, to MH and finally SL, while structural changes in the proximal nerve seem to precede the sensory loss of peripheral nerves and indicate potential targets for the prevention of end-stage DSPN. TRIAL REGISTRATION: ClinicalTrials.gov NCT03022721.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Mooshage CM, Tsilingiris D, Schimpfle L, et al. A diminished sciatic nerve structural integrity is associated with distinct peripheral sensory phenotypes in individuals with type 2 diabetes. Diabetologia. 2023. PMID: 38019287. doi:10.1007/s00125-023-06050-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。